Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins

Nawal Helmi, Abdullah Hamadi, Osama M. Al-Amer, Hassan A. Madkhali, Atif Abdulwahab A. Oyouni, Amany I. Alqosaibi, Jawaher Almulhim, Rashed Mohammed Alghamdi, Israa J. Hakeem, Misbahuddin M. Rafeeq

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science